Diabetes complications

Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors

Diabetes Obes MetabPublished Retrospective cohort study

Authors' conclusion

Physicians should be vigilant for the potential adverse effects of abrupt eGFR dipping associated with a profound reduction in UACR, despite the favourable long-term kidney outcomes in the population with T2D receiving SGLT2 inhibitor treatment.

Study context

Population
People with T2D receiving SGLT2 inhibitors, multicentre healthcare institute in Taiwan, 1 June 2016 to 31 December 2021
Participants
8,310 people
Exposure
Categories of early urine albumin-to-creatine ratio (UACR) change after 3 months of SGLT2i treatment
  • >30% decreasen = 3,062
  • 0%-30% decreasen = 1,743
  • 0%-30% increasen = 1,199
  • >30% increasen = 2,306
Outcome
Acute eGFR change by UACR change group
Follow-up
3 months
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

>30% decrease

−3.6

± 10.9 · mL/min/1.73 m²

0%-30% decrease

−2.0

± 9.5 · mL/min/1.73 m²

0%-30% increase

−1.1

± 8.6 · mL/min/1.73 m²

>30% increase

−0.3

± 9.7 · mL/min/1.73 m²

P < 0.001

Observational data: associations, not effects.

Further findings

>30% initial estimated glomerular filtration rate (eGFR) decline · median 29.0 months

HR (95% CI)
>30% decreaseAfter multivariate adjustment2.68 (1.61–4.47)

Major adverse renal events (MARE) (>50% eGFR reduction or end-stage kidney disease) · median 29.0 months

HR (95% CI)
>30% decreaseAfter multivariate adjustment0.66 (0.48–0.89)

Major adverse cardiovascular events (MACE) or hospitalization for heart failure (HHF) · median 29.0 months

>30% UACR decline associated with a comparable risk of MACE or HHF

Nonlinear analysis

Early UACR decline linked to lower risk of MARE but higher risk of initial steep eGFR decline of >30%

Original publication

Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors. Diabetes Obes Metab. Published 1 July 2024. doi:10.1111/dom.15734

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.